Oscar has led AI strategic initiatives and product development across ​Fortune 50 (Johnson & Johnson) and VC-backed biotech (PathAI) ​companies, bringing a unique lens into the rapidly changing ecosystem of AI ​for life sciences. Oscar has expertise in AI product strategy, pharma-tech ​partnering, AI startup diligence, and validation and regulatory strategies. ​Oscar is also passionate about mentoring startups and participating in ​Accelerators and Incubators within the Cambridge / Boston community.

Oscar has conducted AI research ​in industry and academia, including at MIT and Duke. Collectively, Oscar’s ​research has produced 130+ articles and presentations in top-tier journals ​(e.g. Nature Medicine, Nature Comms) as well as technical and clinical ​conferences. Oscar’s experience includes AI/ML (computer vision, ​generative AI, foundational models) in biopharma R&D and diagnostics ​across multiple diseases (ONC, IMM, CVM, ophthalmology).

Oscar holds a BS from Texas A & M University and PhD from Duke University both in Biomedical Engineering.